VIJAY NAMBI to Patient Selection
This is a "connection" page, showing publications VIJAY NAMBI has written about Patient Selection.
Connection Strength
0.160
-
Implications for Ezetimibe Therapy Use Based on IMPROVE-IT Criteria. Am J Med. 2015 Nov; 128(11):1253-6.
Score: 0.085
-
Role of biomarkers in developing new therapies for vascular disease. World J Surg. 2007 Apr; 31(4):676-81.
Score: 0.048
-
Eligibility and Cost for Icosapent Ethyl Based on the REDUCE-IT Trial. Circulation. 2019 03 05; 139(10):1341-1343.
Score: 0.027